文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

急诊科感染性疾病快速诊断试验综述

Rapid diagnostic tests for infectious diseases in the emergency department.
PubMed 文献 · Clin Microbiol Infect · 2020-02-29

该叙述性综述检索PubMed至2019年8月,纳入FDA或CE批准的、可在全自动系统运行且2小时内出结果的商业化快速诊断试验,按临床综合征分类概述其性能及对临床结局和抗菌药物使用的影响。作者指出临床医生应熟悉各试验特征并预规划工作流程整合,仍需更多临床研究评估其临床效果与成本效益。

要点

  • 快速诊断试验周转时间小于2小时,有望改善急诊患者管理、抗菌药物管理和感染防控。
  • 纳入试验为FDA或CE批准、有临床样本数据、全自动运行且2小时内出结果的商业化检测。
  • 临床医生应熟悉每个快速诊断试验的特征和各自标靶的性能,整合需预先规划。

核心结论

  • 快速诊断试验有望改善急诊患者管理、抗菌药物管理和感染防控,但成功实施依赖其性能和临床影响。
  • 临床医生应熟悉每个快速诊断试验的独特特征和各自标靶的个体化性能特征。
  • 将快速诊断试验整合到急诊工作流程应结合当地限制条件预先规划。
  • 仍需额外临床研究进一步评估快速诊断试验的临床有效性和成本效益。

研究设计与样本

  • 叙述性综述,检索PubMed截至2019年8月关于感染性疾病快速诊断试验的可用研究。
  • 纳入标准为FDA或CE批准的体外诊断器械、有临床样本数据、可在全自动系统运行且2小时内出结果。
  • 按临床综合征分类列出代表性商业化获批检测,基于临床验证研究描述性能,并讨论对临床结局和抗感染药物使用的影响。

主要发现

  • 按临床综合征分类的快速诊断试验包括咽炎和上呼吸道感染、下呼吸道感染、胃肠道感染、脑膜炎和脑炎、返回旅客发热及性传播感染(含HIV)。
  • 检测性能基于临床验证研究描述。
  • 对临床结局和抗感染药物使用的影响以急诊科研究为重点进行讨论。

关键数值与推荐

  • 纳入的快速诊断试验周转时间小于2小时。
  • 纳入检测为FDA或CE批准的体外诊断器械,且有临床样本数据。
  • 纳入检测需能在全自动系统上运行并在2小时内出结果。

临床怎么用

  • 临床医生应熟悉每个快速诊断试验的独特特征和各自标靶的性能特征。
  • 快速诊断试验整合到急诊工作流程应结合当地限制条件预先规划。

局限性

  • 为叙述性综述,所列为非穷尽性代表性商业化检测列表。
  • 仍需额外临床研究进一步评估快速诊断试验的临床有效性和成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rapid diagnostic tests (RDTs) for infectious diseases, with a turnaround time of less than 2 hours, are promising tools that could improve patient care, antimicrobial stewardship and infection prevention in the emergency department (ED) setting. Numerous RDTs have been developed, although not necessarily for the ED environment. Their successful implementation in the ED relies on their performance and impact on patient management. OBJECTIVES: The aim of this narrative review was to provide an overview of currently available RDTs for infectious diseases in the ED. SOURCES: PubMed was searched through August 2019 for available studies on RDTs for infectious diseases. Inclusion criteria included: commercial tests approved by the US Food and Drug Administration (FDA) or Conformité Européenne (CE) in vitro diagnostic devices with data on clinical samples, ability to run on fully automated systems and result delivery within 2 hours. CONTENT: A nonexhaustive list of representative commercially available FDA- or CE-approved assays was categorized by clinical syndrome: pharyngitis and upper respiratory tract infection, lower respiratory tract infection, gastrointestinal infection, meningitis and encephalitis, fever in returning travellers and sexually transmitted infection, including HIV. The performance of tests was described on the basis of clinical validation studies. Further, their impact on clinical outcomes and anti-infective use was discussed with a focus on ED-based studies. IMPLICATIONS: Clinicians should be familiar with the distinctive features of each RDT and individual performance characteristics for each target. Their integration into ED work flow should be preplanned considering local constraints of given settings. Additional clinical studies are needed to further evaluate their clinical effectiveness and cost-effectiveness.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Bouzid D, Zanella MC, Kerneis S, et al. Rapid diagnostic tests for infectious diseases in the emergency department. Clin Microbiol Infect. 2020. PMID: 32120036. doi:10.1016/j.cmi.2020.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。